Robert Alexander Ingram, Director at Edwards Lifesciences Corp (EW), sold 15,000 shares at $87.72 ($1.3M) on 2012-05-25, disclosed to the SEC on 2012-05-25.
Seasonal sale ($1.3M) by Director — this insider has traded EW in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |